Opendata, web and dolomites

Galastick

A medical device determining the daily amount of breast milk to improve neonatal nutrition andmothers’ psychophysics well-being.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Galastick project word cloud

Explore the words cloud of the Galastick project. It provides you a very rough idea of what is the project "Galastick" about.

150    breastfeeding    biological    proprietary    volunteer    galascreen    donate    screened    midwiferies    feeding    breastfeed    few    certifications    diversity    integration    company    neonatal    assay    assessing    market    strategy    psychological    medically    mothers    depression    immunochromatographic    galastick    nutrition    breastmilk    simply    detecting    absence    health    analyte    warning    babies    occurs    omini    flow    commercialization    feel    hospitals    mother    people    lactation    successfully    prototype    undermining    reduce    device    progressively    disposable    works    pharma    confidence    plan    chain    reached    preliminary    deep    frequent    excess    amount    inadequate    engineer    regulatory    daily    active    donor    uses    newborn    nervousness    tested    sme    infants    lack    reveals    colic    stick    milk    business    crying    certified    trl    medical    improves    starts    samples    wellness    supervised    player    preterm    lateral    onset    human    industrialize   

Project "Galastick" data sheet

The following table provides information about the project.

Coordinator
GALASCREEN SRLS 

Organization address
address: VIA SAVINIO ED. POLIFUNZIONALE DIPTO DI FARM
city: RENDE
postcode: 87036
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://talentlab.calabriainnova.it/galascreen/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.6. (SOCIETAL CHALLENGES - Europe In A Changing World - Inclusive, Innovative And Reflective Societies)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-06-01   to  2016-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GALASCREEN SRLS IT (RENDE) coordinator 50˙000.00
2    OMINI PHARMA SOCIETA A RESPONSABILITA LIMITATA SEMPLIFICATA IT (BUSSERO MILANO) participant 0.00

Map

 Project objective

'Biological diversity among people, reveals that not all mothers are the same. For some of them (not a few) it occurs that they are not able to successfully breastfeed their babies. Breastfeeding without 'feeding' can cause frequent crying and colic in the newborn and nervousness in mothers, lack of confidence in their abilities and depression. A mother starts to feel inadequate, undermining her psychological wellness. On the other hand, several mothers have breastmilk in excess and could donate it to preterm infants in midwiferies, thus promoting the babies' health and reduce hospitals' costs. Galascreen developed a proprietary disposable medical device, GalaStick, determining the lactation onset and the progressively increasing daily amount of breastmilk. The stick uses a lateral flow immunochromatographic assay that works simply detecting the presence (or absence) of a target analyte in the human milk sample. Such an easy to use stick not only improves the neonatal nutrition (warning if any feeding integration is needed), but also the psychological well-being of the mother. GalaStick has reached TRL 6 since a preliminary prototype has been tested with real human milk samples. More than 150 volunteer mothers and human milk donor mothers were successfully screened. Galascreen requires funding to engineer and industrialize the stick prototype and to get it medically certified as a medical device. Both key processes will be supervised and supported by the SME partner Omini Pharma. Phase 1 project will address a deep study on business development strategy and will define the value chain and the commercialization plan, together with assessing the regulatory procedures and certifications to be obtained by both the product and the company in order to be an active player on the medical market.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GALASTICK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GALASTICK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.6.;H2020-EU.2.3.1.)

Charity 24-7 (2017)

A social based online survey platform

Read More  

CAR-E (2017)

Creative Automotive Reuse E-commerce

Read More  

KRTS (2015)

KRTS - The Art of Losing Weight

Read More